CULTIVARIUM · RADIO
← On air
Weird Biology

Genes Fuse To Forge Novel Proteins

Weird Biology · with Sofia & Daniel · Recorded Sep 5, 2026
More episodes → Share on X Read the paper →
Transcript

[SOFIA] Okay, Daniel, this is the good stuff. Imagine everything you thought you knew about how genes work—like, the foundational dogma—just got a little bit… weirder. We've always learned that one gene equals one protein, right? It's neat, it's tidy.

[DANIEL] That's the textbook model, yes. A specific gene, a specific locus on a chromosome, transcribed into an mRNA, translated into its corresponding protein. It's the central dogma, simplified.

[SOFIA] Exactly. But what if I told you that genes, even genes on *different chromosomes*, can buddy up, share their instructions, and create entirely new proteins we've never seen before? Researchers at Harvard Medical School just put out a piece on Phys.org suggesting that this is happening in mammals.

[DANIEL] Hm. So, not just alternative splicing within a single gene, or trans-splicing of exons from the *same* gene, but actual fusion of transcripts from entirely separate genes? That's a significant departure from the standard model. What's the mechanism they're proposing here?

[SOFIA] That's the wild part. They're talking about chimeric mRNAs—meaning, a single mRNA molecule that's a mashup of sequences from two distinct genes. And these chimeras aren't just junk; they're actually getting translated into functional proteins. It’s like two different blueprints getting taped together to build a new kind of machine.

[DANIEL] Functional proteins? That's a strong claim. What kind of evidence did they present for these chimeric mRNAs and their subsequent translation? Because detecting a novel transcript is one thing, but demonstrating it produces a stable, active protein with a defined function requires quite a bit more. Were these observed in specific cell types, under certain conditions, or is this proposed to be a general phenomenon?

[SOFIA] The press release doesn't dive into the specifics of *how* they confirmed functionality or the exact conditions, which is what I'm eager to see in the full paper. But the implication is that these aren't just transcriptional accidents. They're suggesting these novel proteins could be playing roles in normal cellular processes, or even in disease. It really expands our idea of the protein landscape within a cell, right? You're not just looking at 20,000 distinct genes, but potentially a much larger, more dynamic repertoire.

[DANIEL] It certainly would expand the proteome considerably, if these are indeed widespread and functional. My immediate questions would be around the stoichiometry. If two genes are combining, what are the relative expression levels of these chimeric transcripts compared to the individual gene transcripts? Is this a rare event, or a significant fraction of the transcriptome? And what controls did they use to rule out experimental artifacts or read-through transcription that might be misidentified as a true chimera? The distinction between a transcriptional read-through of adjacent genes and a true *de novo* chimeric mRNA from distant loci is critical.

[SOFIA] Absolutely. I’m thinking about the implications for engineering, though. If cells can naturally stitch together transcripts from different genes to make new proteins, could we potentially design systems to do this on purpose? Imagine building multi-domain proteins using this natural cellular machinery, bypassing complex gene fusion constructs. It opens up a whole new way to think about protein diversity and evolution, even if it's only happening at low levels. We're talking about a potential new layer of biological complexity.

[DANIEL] A new layer indeed. And a layer that would require very careful validation to ensure we're observing a robust biological mechanism and not an experimental anomaly. But if it holds up, it certainly challenges some long-held assumptions.